Table 3. Organ-on-a-chip and 2D microfluidic models for drug delivery .
Cells | Culture | Nanoparticle | System | Brief summary of the study | Ref. |
A549 | 2D dish culture | Cerium oxide NPs | - | Oxidative stress and cytotoxicity effects of CeO2 NPs on A549 cells | 166 |
Human bronchoalveolar carcinoma | 2D dish culture | Silica NPs | - | The effect of Silica NPs size on toxicity in bronchoalveolar carcinoma | 167 |
LCC6/Her2 | Droplet based microfluidics | DOX loaded CaCO3-NPs | In this system, the alginate beads were trapped in micro-sieve structures for cell culture in a continuous perfusion system. The environment permitted cell proliferation and the formation of multicellular spheroids. | Dose dependent cytotoxic effects of DOX loaded CaCO2-NPs | 168 |
Human endothelial cell | 2D microfluidic channel | MSN | A simple microfluidic platform with precisely controlled shear stress conditions | Shear stress and endothelial cytotoxicity | 169 |
MDA-MB-435 | Organ-on-a-chip (spheroid formation) | Gold NPs | A tumor-on-a-chip system where incorporation of tumor-like spheroids into a microfluidic channel permits real-time analysis of NP accumulation at physiological flow conditions. | Developing a tumor-on-a-chip system to study the transport of gold NPs through a 3D tissue environment and characterizing NPs within a tumor tissue. | 170 |
Hy926 and human platelet | 2D microfluidic channel | FMS-NPs | The impact of sub-50 nm diameter mesoporous silica nanoparticles on platelet function is investigated using a microfluidic platform to model blood vessel characteristics | The effect of FMS-NPs on platelet aggregation | 171 |
HUVEC | 2D microfluidic channel | Lipid-polymer NPs | Endothelialized microchip with controllable permeability can be used to probe nanoparticle translocation across an endothelial cell layer. | Microfluidic model of atherosclerosis to assessment of NPs endothelial translocation | 172 |
MCF-7 and MVECs | Organ-on-a-chip (Pseudo 3D) | Fluorescent NPs | This model, consists of 3-dimensional microfluidic channels where tumor cells and endothelial cells are cultured within extracellular matrix under perfusion of interstitial fluid | Transport of NPs within the tumor | 173 |
Caco-2, TH29-MTX and HepG2/C3A | 2D microfluidic channel | carboxylated polystyrene NPs | To construct this system, we combined in vitro models of the human intestinal epithelium, represented by a co-culture of Caco-2, TH29-MTX, and HepG2/C3A cells, within one microfluidic device. | Detection of liver injury using GI tract-liver-other tissue system | 174 |
HUVEC | 2D microfluidic channel | Gold NPs | The tests performed in the microfluidic device were also run in multiwells, where no flow is present | Flow dependent cytotoxicity effects of gold NPs on endothelial | 175 |
MCF-7, MDA-MB-231, and SUM-159PT | Organ-on-a-chip (3D gel pattering) | Dox-HANP | Three types of human breast cancer cell lines including MCF-7, MDA-MB-231, and SUM-159PT were cultured on a 3D platform, and their drug response and resistance to doxorubicin were characterized | The effects of NPs mediated drug delivery | 176 |
HUVEC | 2D microfluidic channel | Gold NPs | A microfluidic device to observe how HUVEC viability changes when subject to a continuous flow of culture medium. | The effect of shear stress and gold NPs size on endothelial cytotoxicity | 177 |
HUVEC | Organ-on-a-chip | HDL mimetic NPs | A micro-engineered three-dimensional vascular system | The effect of HDL mimetic NPs on endothelial cells | 178 |
CaCO3: calcium carbonate; CeO2: cerium oxide; DOX: doxorubicin; FMS: fluorescent mesoporous silica; MSN: mesoporous silica nanoparticle; HDL: high density lipoprotein; HANP: hyaluronic acid nanoparticle; gH625: membranotropic peptide; NPs: nanoparticles.